Skip to the page

Data / Drug companies / Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc.: 646 products in the FDA NDC directory, labeler code 31722

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Camber Pharmaceuticals, Inc. (labeler code 31722) lists 646 products in the FDA National Drug Code Directory, covering 226 finished drugs by generic name. By type: 646 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 31, 2026.

The request: Watch Camber Pharmaceuticals, Inc. (FDA labeler code 31722): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
31722
Products in commercial distribution
646
Packages
1,463
Finished drugs by generic name
226
Prescription products
646
Over the counter products
0
Controlled substance products
Schedule II 69, Schedule III 12, Schedule IV 6, Schedule V 14
Flagged as original packager
637 of 637 products that carry the flag
Started marketing in the last 12 months
50
Earliest marketing start
December 7, 2005
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)646100%

Products by type

TypeProductsShare
Prescription drugs646100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lisdexamfetamine dimesylate1316
Lisinopril1240
Aripiprazole1249
Levothyroxine sodium1244
Methylphenidate hydrochloride1039
Topiramate856
Dexmethylphenidate hydrochloride817
Pregabalin854
Oxycodone and acetaminophen832
Gabapentin891
Valsartan838
Atomoxetine719
Sildenafil753
Temozolomide612
Buprenorphine and naloxone622
Quetiapine fumarate633
Deferasirox621
Irbesartan627
Lamotrigine extended-release64
Lacosamide657
Lenalidomide619
Pramipexole61
Lurasidone hydrochloride528
Simvastatin532
Tadalafil554
Potassium chloride584
Bupropion hydrochloride567
Milnacipran hydrochloride56
Olmesartan medoxomil, amlodipine and hydrochlorothiazide52
Oxycodone hydrochloride536
Venlafaxine433
Mirtazapine442
Hydralazine hydrochloride447
Levetiracetam487
Indomethacin436
Metoprolol succinate446
Tolterodine tartrate413
Oseltamivir phosphate437
Spironolactone445
Rosuvastatin419
Hydrocodone bitartrate and acetaminophen437
Hydromorphone hydrochloride420
Paliperidone419
Atorvastatin calcium459
Eslicarbazepine acetate410
Torsemide425
Oxcarbazepine446
Ketorolac tromethamine469
Fluphenazine hydrochloride429
Nebivolol421
Pomalidomide412
Eltrombopag411
Lamivudine414
Captopril414
Darunavir414
Lidocaine hydrochloride4134
Sapropterin dihydrochloride310
Erlotinib35
Bupivacaine hydrochloride323
Phenylephrine hydrochloride377
Amlodipine and olmesartan medoxomil310
Mesalamine341
Acyclovir370
Famciclovir312
Levofloxacin342
Olmesartan medoxomil and hydrochlorothiazide317
Dronabinol37
Potassium citrate317
Sertraline hydrochloride355
Furosemide363
Carbidopa and levodopa341
Avanafil31
Hydroxyzine hydrochloride351
Lithium carbonate324
Clobazam318
Dimethyl fumarate320
Losartan potassium and hydrochlorothiazide331
Olmesartan medoxomil331
Venlafaxine hydrochloride348
Mexiletine hydrochloride316
Famotidine3138
Cisatracurium besylate315
Sacubitril and valsartan329
Montelukast sodium331
Afatinib32
Duloxetine336
Zinc sulfate37
Dabigatran etexilate317
Atazanavir34
Droxidopa315
Cinacalcet318
Varenicline tartrate323
Losartan potassium343
Eszopiclone329
Pitavastatin calcium310
Rufinamide312
Bumetanide242
Maraviroc29
Lopinavir and ritonavir24
Donepezil hydrochloride234

Dosage forms

Dosage formProductsShare
Tablet, film coated18929.3%
Tablet15323.7%
Capsule8112.5%
Tablet, extended release294.5%
Capsule, extended release274.2%
Solution243.7%
Injection, solution223.4%
Tablet, film coated, extended release172.6%
Injection142.2%
Injection, powder, lyophilized, for solution121.9%
Tablet, chewable111.7%
Capsule, delayed release111.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Clomiphene Citrate31722-541TabletGeneric drugs (ANDA)August 31, 2026
Glycerol Phenylbutyrate31722-605LiquidGeneric drugs (ANDA)August 21, 2026
Sugammadex31722-255Injection, solutionGeneric drugs (ANDA)July 27, 2026
Sugammadex31722-254InjectionGeneric drugs (ANDA)July 27, 2026
Afatinib31722-783Tablet, film coatedGeneric drugs (ANDA)July 14, 2026
Afatinib31722-782Tablet, film coatedGeneric drugs (ANDA)July 14, 2026
Afatinib31722-781Tablet, film coatedGeneric drugs (ANDA)July 14, 2026
Diphenhydramine hydrochloride31722-601SolutionGeneric drugs (ANDA)June 17, 2026
Diphenhydramine hydrochloride31722-600SolutionGeneric drugs (ANDA)June 17, 2026
Losartan potassium and hydrochlorothiazide31722-757Tablet, film coatedGeneric drugs (ANDA)May 27, 2026
Losartan potassium and hydrochlorothiazide31722-756Tablet, film coatedGeneric drugs (ANDA)May 27, 2026
Losartan potassium and hydrochlorothiazide31722-755Tablet, film coatedGeneric drugs (ANDA)May 27, 2026
L-glutamine31722-483Powder, for solutionGeneric drugs (ANDA)May 26, 2026
Cisatracurium Besylate31722-314InjectionGeneric drugs (ANDA)May 4, 2026
Cisatracurium Besylate31722-313InjectionGeneric drugs (ANDA)May 4, 2026
Cisatracurium Besylate31722-312InjectionGeneric drugs (ANDA)May 4, 2026
Buprenorphine and Naloxone31722-482Film, solubleGeneric drugs (ANDA)May 1, 2026
Buprenorphine and Naloxone31722-481Film, solubleGeneric drugs (ANDA)May 1, 2026
Buprenorphine and Naloxone31722-480Film, solubleGeneric drugs (ANDA)May 1, 2026
Buprenorphine and Naloxone31722-479Film, solubleGeneric drugs (ANDA)May 1, 2026
Topiramate31722-550Capsule, extended releaseGeneric drugs (ANDA)April 1, 2026
Topiramate31722-549Capsule, extended releaseGeneric drugs (ANDA)April 1, 2026
Topiramate31722-548Capsule, extended releaseGeneric drugs (ANDA)April 1, 2026
Topiramate31722-547Capsule, extended releaseGeneric drugs (ANDA)April 1, 2026
Milnacipran hydrochloride31722-880KitGeneric drugs (ANDA)March 19, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.